Ruoslahti Research Laboratories at UC Santa Barbara and Sanford-Burnham
  • Upload

  • Log in

  • Sign up

Search on MyScienceWork
News Publications Members

Publication search

Sort by
  • Relevance
  • Published Date

The C-type lectin domains of lecticans, a family of aggregating chondroitin sulfate proteoglycans, bind tenascin-R by pr...

Aspberg, A Miura, R Bourdoulous, S Shimonaka, M Heinegârd, D Schachner, M Erkki Ruoslahti Yamaguchi, Y

Published in Proceedings of the National Academy of Sciences

The lecticans are a family of chondroitin sulfate proteoglycans including aggrecan, versican, neurocan, and brevican. The C-terminal globular domains of lecticans are structurally related to selectins, consisting of a C-type lectin domain flanked by epidermal growth factor and complement regulatory protein domains. The C-type lectin domain of versi...

Molecular cloning and sequence analysis of a chondroitin sulfate proteoglycan cDNA.

Bourdon, Ma Oldberg, A Pierschbacher, M Erkki Ruoslahti

Published in Proceedings of the National Academy of Sciences

We report the identification and DNA sequence of a chondroitin sulfate proteoglycan core protein cDNA. A cDNA clone, pPG1, was selected from a rat yolk sac tumor poly(A)+RNA-derived cDNA library by using synthetic oligonucleotides predicted from the NH2-terminal peptide sequence of the mature chondroitin sulfate proteoglycan. The resulting sequence...

A fragment of the HMGN2 protein homes to the nuclei of tumor cells and tumor endothelial cells in vivo.

Porkka, K Laakkonen, P Hoffman, Ja Bernasconi, M Erkki Ruoslahti

Published in Proceedings of the National Academy of Sciences

We used a screening procedure to identify protein domains from phage-displayed cDNA libraries that bind both to bone marrow endothelial progenitor cells and tumor vasculature. Screening phage for binding of progenitor cell-enriched bone marrow cells in vitro, and for homing to HL-60 human leukemia cell xenograft tumors in vivo, yielded a cDNA fragm...

Specific penetration and accumulation of a homing peptide within atherosclerotic plaques of apolipoprotein E-deficient m...

Hamzah, J V. Ramana Kotamraju Seo, Jw Lilach Agemy Valentina Fogal Mahakian, Lm Peters, D Lise Roth Gagnon, Mk Ferrara, Kw ...

Published in Proceedings of the National Academy of Sciences

The ability to selectively deliver compounds into atherosclerotic plaques would greatly benefit the detection and treatment of atherosclerotic disease. We describe such a delivery system based on a 9-amino acid cyclic peptide, LyP-1. LyP-1 was originally identified as a tumor-homing peptide that specifically recognizes tumor cells, tumor lymphatics...

Targeting atherosclerosis by using modular, multifunctional micelles

Peters, David Kastantin, Mark Kotamraju, Venkata Ramana Karmali, Priya P. Gujraty, Kunal Tirrell, Matthew Ruoslahti, Erkki

Published in Proceedings of the National Academy of Sciences of the United States of America

Subtle clotting that occurs on the luminal surface of atherosclerotic plaques presents a novel target for nanoparticle-based diagnostics and therapeutics. We have developed modular multifunctional micelles that contain a targeting element, a fluorophore, and, when desired, a drug component in the same particle. Targeting atherosclerotic plaques in ...

Cooperative nanomaterial system to sensitize, target, and treat tumors.

Jh, Park G, Von Maltzahn Mj, Xu V, Fogal Vr, Kotamraju E, Ruoslahti Sn, Bhatia Mj, Sailor

Published in Proceedings of the National Academy of Sciences

A significant barrier to the clinical translation of systemically administered therapeutic nanoparticles is their tendency to be removed from circulation by the mononuclear phagocyte system. The addition of a targeting ligand that selectively interacts with cancer cells can improve the therapeutic efficacy of nanomaterials, although these systems h...

Fibronectin synthesis by epithelial crypt cells of rat small intestine.

Quaroni, A Isselbacher, Kj Erkki Ruoslahti

Published in Proceedings of the National Academy of Sciences

Synthesis of fibronectin in an epithelial cell line (IEC-6) established from rat small intestine was demonstrated by using immunofluorescence, radioimmunoassay, and collagen-binding. Internally labeled radioactive fibronectin isolated from the IEC-6 cells gave a single main band in sodium dodecyl sulfate/polyacrylamide gel electrophoresis under red...

A 125/115-kDa cell surface receptor specific for vitronectin interacts with the arginine-glycine-aspartic acid adhesion ...

Pytela, R Pierschbacher, Md Erkki Ruoslahti

Published in Proceedings of the National Academy of Sciences

Affinity chromatography was used to identify a cell surface receptor for the adhesive protein vitronectin. Detergent extracts of human osteosarcoma (MG-63) cells were chromatographed on either vitronectin-Sepharose or Sepharose linked to the synthetic peptide Gly-Arg-Gly-Asp-Ser-Pro, which includes the fibronectin cell attachment sequence Arg-Gly-A...

Immunological crossreaction between alpha-fetoprotein and albumin.

Erkki Ruoslahti Engvall, E

Published in Proceedings of the National Academy of Sciences

Alpha-fetoprotein (AFP), a fetal protein associated with certain tumors, and serum albumin did not corssreact immunologically in native form. Unfolding of their polypeptide chains by reduction of the disulfide bonds followed by carboxamidomethylation produced derivatives with immunochemical properties different from those of the native proteins. Pr...

Variants of the cell recognition site of fibronectin that retain attachment-promoting activity.

Pierschbacher, Md Erkki Ruoslahti

Published in Proceedings of the National Academy of Sciences

A tetrapeptide sequence, Arg-Gly-Asp-Ser, is the minimal structure recognized by cells in the large, adhesive glycoprotein fibronectin. We now have defined the structural requirements for this cell recognition site by testing several synthetic variants of the active tetrapeptide sequence. The conservative substitutions of lysine for arginine, alani...

  • ← Previous
  • 1 (current)
  • 2
  • 3
  • 4
  • 5
  • Next →
Powered by Polaris
  • About the Lab
  • Our Research
  • About this Platform
  • FAQ